A Study of Azacitidine in Myelodysplastic Syndrome (MDS) Associated to Systemic Auto-immune and Inflammatory Disorders

NCT02985190 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

MDS
Systemic Autoimmune Diseases

Interventions

DRUG: Azacitidine

Sponsor

Groupe Francophone des Myelodysplasies

Collaborators

[object Object]